Related Experiment Videos

Disordered calcium crystal handling in antisense CLC-5-treated collecting duct cells

John A Sayer1, Georgina Carr, Simon H S Pearce

  • 1Department of Medicine, University of Newcastle Upon Tyne, Medical School, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK. j.a.sayer@ncl.ac.uk

Insights

Dent's disease, caused by chloride channel CLC-5 defects, leads to kidney stones. Disrupting CLC-5 function impairs endocytosis and causes abnormal calcium oxalate crystal buildup in kidney cells.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Dent's disease is an X-linked tubulopathy linked to chloride channel CLC-5 defects.
  • It presents with low molecular weight proteinuria, hypercalciuria, nephrocalcinosis, and renal stones.
  • The mechanisms underlying nephrocalcinosis in Dent's disease remain unclear.

Purpose of the Study:

  • To investigate the role of CLC-5 in endosomal acidification and endocytosis.
  • To explore the impact of CLC-5 disruption on calcium oxalate crystal handling in kidney cells.

Main Methods:

  • Utilized a murine collecting duct cell line (mIMCD-3) expressing endogenous CLC-5.
  • Employed antisense CLC-5 transfection to reduce protein expression.
  • Assessed endosomal acidity using LysoTracker Red and confocal microscopy.
  • Evaluated endocytosis using wheat germ agglutinin-lectin.
  • Exposed cells to calcium oxalate crystals to observe agglomeration.

Main Results:

  • Reduced CLC-5 protein expression correlated with fewer acidic endosomal compartments.
  • Disruption of CLC-5 led to an arrest in endocytosis.
  • Cells with reduced CLC-5 exhibited abnormal calcium oxalate crystal agglomeration.

Conclusions:

  • CLC-5 expression in mIMCD-3 cells is crucial for endosomal acidification and endocytosis.
  • Disruption of CLC-5 function results in aberrant crystal agglomeration, potentially contributing to nephrocalcinosis in Dent's disease.

Related Concept Videos